Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00033826 · ClinicalTrials.gov registry record
Role of Fat Tissue in Vitamin D Metabolism
A clinical trial, sponsored by Tufts University.
- Completed
- Registry status
- 41
- Enrollment target
NCT00033826: Completed study, sponsored by Tufts University.
NCT00033826 is a clinical trial that has completed, run by Tufts University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00033826 has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
Vitamin D is a fat soluble vitamin that has important effects on calcium (including absorption of calcium from the diet) and bone metabolism. Vitamin D is known to be stored in fat tissue, and it is also present in the circulation. The purpose of this study is to investigate the relationship between levels of vitamin D in fat tissue and in blood.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2002-04 |
| Est. Completion | 2007-09 |
What the finished NCT00033826 record still lists
NCT00033826 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00033826 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00033826 about?
NCT00033826 is a clinical study titled "Role of Fat Tissue in Vitamin D Metabolism". Vitamin D is a fat soluble vitamin that has important effects on calcium (including absorption of calcium from the diet) and bone metabolism. Vitamin D is known to be stored in fat tissue, and it is also present in the circulation. The purpose of this study is to investigate the relationship between...
What is the current status of trial NCT00033826?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2002-04. Estimated completion is 2007-09.
Who is sponsoring clinical trial NCT00033826?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia